Cocaine drug addiction during pregnancy and subsequent child developmental consequences;Consequences de la toxicomanie a la cocaine pendant la grossesse sur le developpement de l'enfant

Archives de Pediatrie

Volumn 4, Issue 7, 1997, Pages 677-682

  Ferraro, F ^a   Ferraro, R ^a   Massard, A ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Cocaine; Drug addiction; Fetal malformations

Indexed keywords

BRAIN DEVELOPMENT; CHILD DEVELOPMENT; CONGENITAL MALFORMATION; DRUG DEPENDENCE; FETUS CIRCULATION; FETUS DEVELOPMENT; NEUROTRANSMITTER RELEASE; PATHOGENESIS; PREGNANCY; PRENATAL EXPOSURE; REVIEW; UTERUS BLOOD FLOW; ADDICTION; CHILD; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; HUMAN; NEWBORN; PREGNANCY COMPLICATION; PRENATAL DEVELOPMENT; UTERUS;

COCAINE;

CHILD; CHILD DEVELOPMENT; COCAINE; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE-RELATED DISORDERS; UTERUS;

EID: 0031179853     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)83373-8     Document Type: Review

References (42)

1. Kain ZN, Rimar S, Barash PG. Cocaine abuse in the parturient and effects on the fetus and neonate. Anesth Analg 1993; 77:835-45
2. Jackson Barton S, Harrigan R, Tse AM. Prenatal cocaine exposure: implications for practice, policy development, and needs for future research. J Perinatol 1995;15:10-22
3. Bongain A, Huss M, Gillet JY. Toxicomanie et grossesse. Rev Prat 1992;42:1004-9
4. Ciraru-Vigneron N, Rafowicz E, Nguyen Tan Lung R et al. Toxicomanie et grossesse. Principales conséquences obstétricales et pédiatriques. J Gynécol Obstet Biol Reprod 1989; 18:637-48
5. Parquet PJ, Bailly D, Vignau J, Servant D. Toxicomanie et grossesse. Une situation nouvelle et méconnue. Sem Hôp Paris 1988;64:1649-54
6. e Journée parisienne obstétrico-pédiatrique. Toxicomanie et grossesse - Rupture prématurée des membranes. Paris: Doin, 1995:24-34
7. De Vane CL, Burchfield DJ, Abrams RM et al. Disposition of cocaine in pregnant sheep. Dev Pharmacol Ther 1991;16: 123-9
8. 2 adrenergic receptor binding in pregnant human myometrium. Am J Obstet Gynecol 1993;169: 644-9
9. Plessinger MA, Woods JR. Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol 1993;36:267-76
10. Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986; 108:456-9
11. Klein J, Greenwald M, Becker L, Koren G. Fetal distribution of cocaine: case analysis. Pediatr Pathol 1992;12:463-8
12. Szeto HH. Kinetics of drug transfer to the fetus. Clin Obstet Gynecol 1993;36:246-54
13. Hsu CD, Chen S, Feng TI, Johnson TRB. Rupture of uterine scar with extensive maternal bladder laceration after cocaine abuse. Am J Obstet Gynecol 1992;167:129-30
14. Gonsoulin W, Borge D, Moise KJ. Rupture of unscarred uterus in primigravid woman in association with cocaine abuse. Am J Obstet Gynecol 1990;163:526-7
15. Jacobson JL, Jacobson SW, Sokol RJ et al. Effects of alcohol use, smoking, and illicit drug use on fetal growth in black infants. J Pediatr 1994;124:757-64
16. Cohen HR, Green JR, Crombleholme WR. Peripartum cocaine use: estimating risk of adverse pregnancy outcome. Int J Gynaecol Obstet 1991;35:51-4
17. Zuckerman B, Frank DA. Prenatal cocaine exposure: nine years later. J Pediatr 1994;124:731-3
18. Shannon M, Lacouture PG, Roa J, Woolf A. Cocaine exposure among children seen at a pediatric hospital. Pediatrics 1989; 83:337-42
19. Kliegman RM, Madura D, Elsenberg I, Yamashita T. Relation of maternal cocaine use to the risk of prematurity and low birth weight. J Pediatr 1994;124:751-6
20. Singer LT, Yamashita TS, Hawkins S et al. Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants. J Pediatr 1994;124:765-71
21. Woods JR, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 1987; 257:957-61
22. Zuckerman B, Frank DA, Hingson R et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762-8
23. Dicke JM, Verges DK, Polakoski KL. The effects of cocaine on neutral amino-acid uptake by human placental basal membrane vesicles. Am J Obstet Gynecol 1994;171:485-91
24. Webster W, Brown-Woodman PDC. Cocaine as cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 1990;41:689-97
25. Bingol N, Fuchs M, Diaz V et al. Teratogenicity of cocaine in humans. J Pediatr 1987;110:93-6
26. Chavez RF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 1989;262:795-8
27. Sarpong S, Headings V. Sirenomelia accompanying exposure of the embryo to cocaine. South Med J 1992;85:545-7
28. Chasnoff IJ, Chisum GM, Kaplan WE. Maternal cocaine use and genitourinary tract malformations. Teratology 1988; 37:201-4
29. Louise Martin M, Khoury MJ, Cordero JF. Trends in rates of multiple vascular disruption defects, Atlanta, 1968-1989: is there evidence of cocaine teratogenic epidemic? Teratology 1992;45:647-53
30. Evrard P. Cinq mille neurones àla seconde. Sciences & Vie 1995;190(hors série):88-95
31. Van de Bor M, Walther FJ, Ebrahimi M. Decreased cardiac output in infants of mothers who abused cocaine. Pediatrics 1990;85:30-2
32. Horn PT. Persistent hypertension after prenatal cocaine exposure. J Pediatr 1992;121:288-91
33. Hall TR, Zaninovic A, Lewin D et al. Neonatal intestinal ischemia with bowel perforation: an in utero complication of maternal cocaine abuse. AJR 1992;158:1303-4
34. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989;115:770-8
35. Dusick AM, Covert RF, Schreiber MD et al. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J Pediatr 1993;122:438-45
36. Salamy A, Eldredge L, Anderson J, Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr 1990;117:627-9
37. Van Baar AL, Fleury P, Ultee CA. Behaviour in first year after drug dependent pregnancy. Arch Dis Child 1989;64:241-5
38. Singer LT, Garber R, Kliegman R. Neurobehavioral sequelae of fetal cocaine exposure. J Pediatr 1991;119:667-72
39. Davis E, Fennoy I, Laraque D et al. Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 1992;84:315-9
40. Bauchner H, Zuckerman B, McClain M et al. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr 1988;113:831-4
41. Leventhal JM, Garber RB, Brady CA. Identification during the postpartum period of infants who are at high risk of child maltreatment. J Pediatr 1989;114:481-7
42. Marcenko MO, Spence M, Rohweder C. Psychosocial characteristics of pregnant women with and without a history of substance abuse [published erratum appears in Health Soc Work 1994;19:198]. Health Soc Work 1994;19:17-22